Clinical trials
Phase 1/2 Myelodysplastic Syndromes trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2016 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Completed | 2 |
| Terminated | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 1 |
| BeOne Medicines | 1 |
| Disc Medicine, Inc | 1 |
| Ellipses Pharma | 1 |
| Forma Therapeutics, Inc. | 1 |
| Humanigen, Inc. | 1 |
| Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA) | 1 |
| PedAL BCU, LLC | 1 |
| Sanofi | 1 |
| Servier Bio-Innovation LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myelodysplastic Syndromes | 10 |
| Leukemia, Myeloid, Acute | 7 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Leukemia, Myelomonocytic, Chronic | 2 |
| Myeloproliferative Disorders | 2 |
| Primary Myelofibrosis | 2 |
| Anemia | 1 |
| Leukemia | 1 |
| Leukemia, Biphenotypic, Acute | 1 |
| Leukemia, Myelomonocytic, Juvenile | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.